SUMMARY A regional quality control trial of paediatric bilirubin analyses is described. The overall performance of the group was unsatisfactory with an unacceptably high inter-laboratory variation.
Paediatric bilirubin analyses are essential in the management of neonates, especially if they become or remain jaundiced several days after birth. Clinical decisions whether to institute phototherapy or exchange transfusion are highly dependent upon the results of such analyses.
Most laboratories employ techniques for the analysis of paediatric specimens that are different from those used for adult patients and, while methodologies appropriate to the latter feature in most external quality control surveys such as the College of American Pathologists Survey and Wellcome Group Quality Control Programme, little attention has been devoted to inter-laboratory quality control trials for paediatric bilirubins. Accordingly, we have conducted an inter-laboratory quality control survey of this analysis within South Australia.
Material and methods Table 1 shows the laboratories, the methods they used, and their methods of standardization. Laboratories using two methods are entered twice, for example, Al, A2.
The methods used in the various laboratories were: 1 Differential spectroscopy by one of two methods (a) dilution of plasma in phosphate buffer and measurement of the absorbance at 455 and 575 nm (White et al., 1958) Table 4 were distributed only once. All commercial sera were reconstituted according to the manufacturer's specifications, diluted further if required, and aliquoted accordingly. Diluted specimens were found to remain stable for 36 hours provided they were kept at 4°C and protected from the light. Two types of human material were distributed: pooled adult plasma from jaundiced, hepatitis B antigen negative subjects and post-exchange plasma from a neonate with Rh incompatibility.
All specimens were distributed in plastic tubes. Care was taken to protect them from the light during and after preparation. Laboratories were asked to store specimens at 4°-8°C and to analyse them at the same time.
If laboratories were unable to analyse the specimens at the date and time requested they were asked to inform us accordingly so that we could exclude such results from the final calculations. In this way we minimised possible differences in results due to changes in the material distributed. In view of the considerable distance that some laboratories were from the distribution point the time of analysis was approximately 30-36 hours after preparation.
Results and discussion
Paediatric bilirubin analyses should be accurate and precise in view of their clinical importance. There are several biochemical criteria for clinical intervention when treating jaundiced neonates. One criterion is the rate of increase of the plasma bilirubin concentration. Swyer (1975) states that a bilirubin concentration increasing more than 8 ,umol/l (0 5 mg/100 ml) /h is an indication for exchange transfusion. The aim of the laboratory should, therefore, be to produce precise results that can confidently detect a change of concentration between two samples taken a few hours apart. Lathe (1970) has pointed out that difficulties in patient management may arise if too short a time interval between analyses is chosen when looking for significant changes in bilirubin concentration. However, it is our experience that such advice is largely unheeded, and when there is a possibility that an exchange transfusion may be required, clinicians commonly request analyses at too short time intervals. stituent (Whitehead et al., 1973) . However, it is clear that the group performance in terms of accuracy does not meet clinical requirements. Because of the variation in standards (Table 1 ) we investigated the effect on inter-laboratory variation when all laboratories used a common standard. All laboratories used a neonatal plasma, to which we had assigned a value approximating its true bilirubin concentration as an alternative to their normal standard material. In Table 5 we compare the values obtained from laboratories for commercial and human sera using their own and our standard. The mean values for the human sera are not significantly different (P > 0 5) whereas the means for commercial lyophilised sera differ significantly (0 01 < P < 0 05). Furthermore, when the common standard was used the inter-laboratory precision improved significantly (P < 0-05) in both instances. This improvement in performance could be expected when all laboratories used a common standard. However, it does reinforce the need for laboratories in a common geographical area to agree on the use of such a standard. (Billing et al., 1971; Doumas et al., 1973) . In a paediatric laboratory, where one is dealing with very small samples, diazo methods such as Jendrassik and Grof, or Malloy and Evelyn, involve a number of manipulations with very small volumes and thus require considerable expertise. Spectroscopy techniques require only a preliminary dilution step and therefore allow for fewer potential errors to occur. This is reflected by the marked improvement in precision, compared to diazo procedures, when using these simple methods.
In this laboratory, each of 19 'on-call' personnel was asked to measure the bilirubin concentration of a neonatal plasma using both a bilirubinometer and a Jendrassik and Grof technique. The mean values obtained were 239 and 241 umol/l respectively. However the bilirubinometer results gave a coefficient of variation of 1 3 % compared with 5-1 % for the Jendrassik and Grof method. Attention has recently been drawn by Ebbesen (1977) to the method simplicity of spectrophotometry. It is also noted that a one-step modification of the Malloy-Evelyn procedure has recently been proposed by Shihabi and Scaro (1977) . The suggested advantage of diazo procedures such as Michadlsson's over spectroscopy has been their ability to overcome interferences. However, extensive work by Hertz et al. (1974) into various formulae used for calculating bilirubin concentrations by direct spectroscopy has shown that carefully derived formulae can compensate for interferences from haemoglobin, methaemalbumin, and turbidity, producing good agreement between this method and diazo procedure.
We It may be significant that no laboratory was using prepared bilirubin standards, as has been recommended by a number of groups (Joint Committee Report, 1962; Billing et al., 1971) . Such standards are difficult to prepare, however, and the work involved would probably be beyond the facilities of our smaller laboratories.
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